The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm

Oral Microbiology and Immunology

Volumn 21, Issue 6, 2006, Pages 366-371

  Takahashi, N ^a   Ishihara, K ^a   Kimizuka, R ^a   Okuda, K ^a   Kato, T ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Antibiotics; Biofilm; Periodontitis; Prevotella intermedia

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; MINOCYCLINE; OFLOXACIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG INHIBITION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PERIODONTAL DISEASE; PERIODONTITIS; PREVOTELLA INTERMEDIA;

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; DOXYCYCLINE; LUMINESCENCE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OFLOXACIN; PREVOTELLA INTERMEDIA; TETRACYCLINE; TETRACYCLINES;

EID: 33750309179     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2006.00305.x     Document Type: Article

References (39)

1. Albandar JM, Brown LJ, Loe H. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol 1997: 68: 973-981.
2. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996: 11: 266-273.
3. Brook I, Frazier EH. Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis. Chest 2003: 124: 832-833.
4. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995: 49: 711-745.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999: 284: 1318-1322.
6. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV. Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 2005: 76: 731-736.
7. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res 1997: 11: 160-167.
8. Kamma JJ, Nakou M, Gmur R, Baehni PC. Microbiological profile of early onset/aggressive periodontitis patients. Oral Microbiol Immunol 2004: 19: 314-321.
9. Killoy WJ. Chemical treatment of periodontitis: local delivery of antimicrobials. Int Dent J 1998: 48: 305-315.
10. Kimura S, Toda H, Shimabukuro Y et al. Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation. J Periodontal Res 1991: 26: 33-41.
11. Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 2000: 54: 413-437.
12. Kumon H, Ono N, Iida M, Nickel JC. Combination effects of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob Agents Chemother 1995: 39: 1038-1044.
13. Kuru B, Yilmaz S, Noyan U, Acar O, Kadir T. Microbiological features and crevicular fluid aspartate aminotransferase enzyme activity in early onset periodontitis patients. J Clin Periodontol 1999: 26: 19-25.
14. Lakhssassi N, Elhajoui N, Lodter JP, Pineill JL, Sixou M. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study. Oral Microbiol Immunol 2005: 20: 244-252.
15. Lewis W. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001: 45: 999-1007.
16. Marsh PD. Dental plaque as a microbial biofilm. Caries Res 2004: 38: 204-211.
17. Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. J Periodontal Res 1995: 30: 290-293.
18. Mombelli A, Tonetti M, Lehmann B, Lang NP. Topographic distribution of black-pigmenting anaerobes before and after periodontal treatment by local delivery of tetracycline. J Clin Periodontol 1996: 23: 906-913.
19. Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from prepuberty to puberty of gingivitis. Correlation between the occurrence of Prevotella intermedia and sex hormones. J Clin Periodontol 1994: 21: 658-665.
20. Noiri Y, Li L, Ebisu S. The localization of periodontal-disease- associated bacteria in human periodontal pockets. J Dent Res 2001: 80: 1930-1934.
21. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T, Ebisu S. Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol 2003: 74: 1647-1651.
22. Novak MJ. Necrotizing ulcerative periodontitis. Ann Periodontol 1999: 4: 74-78.
23. Petit MDA, van Steenbergen TJM, Timmerman MF, de Graaff J, van der Velden U. Prevalence of periodontitis and suspected periodontal pathogens in families of adult periodontitis patients. J Clin Periodontol 1994: 21: 76-85.
24. Polson AM, Garrett S, Stoller NH et al. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 1997: 68: 119-126.
25. Rowland RW, Mestecky J, Gunsolley JC, Cogen RB. Serum IgG and IgM levels to bacterial antigens in necrotizing ulcerative gingivitis. J Periodontol 1993: 64: 195-201.
26. Saito A, Hosaka Y, Nakagawa T, Seida K, Yamada S, Okuda K. Locally delivered minocycline and guided tissue regeneration to treat post-juvenile periodontitis. A case report. J Periodontol 1994: 65: 835-839.
27. Sbordone L, Bortolaia C. Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clin Oral Investig 2003: 7: 181-188.
28. Shinzato T, Saito A. A mechanism of pathogenicity of 'Streptococcus milleri group' in pulmonary infection: synergy with an anaerobe. J Med Microbiol 1994: 40: 118-123.
29. Slots J, Jorgensen MG. Effective, safe, practical and affordable periodontal antimicrobial therapy; where are we going, and are we there yet? Periodontol 2000 2002: 28: 298-312.
30. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002: 28: 106-176.
31. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002: 28: 12-55.
32. Takahashi N, Saito K, Schachtele CF, Yamada T. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol 1997: 12: 323-328.
33. Tsuruda K, Miyake Y, Suginaka H, Okamoto H, Iwamoto Y. Microbiological features of gingivitis in pubertal children. J Clin Periodontol 1995: 22: 316-320.
34. Van der Weijden GA, Timmerman MF, Reijerse E, Wolffe GN, Van Winkelhoff AJ, Van der Velden U. The prevalence of A. actinomycetemcomitans, P. gingivalis and P. intermedia in selected subjects with periodontitis. J Clin Periodontol 1994: 21: 583-588.
35. van Winkelhoff AJ, Winkel EG. Systemic antibiotic therapy in severe periodontitis. Curr Opin Periodontol 1997: 4: 35-40.
36. Whittaker CJ, Klier CM, Kolenbrander PE. Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 1996: 50: 513-552.
37. Wilson M, Patel H, Fletcher J. Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride. Oral Microbiol Immunol 1996: 11: 188-192.
38. Wright TL, Ellen RP, Lacroix JM, Sinnadurai S, Mittelman MW. Effects of metronidazole on Porphyromonas gingivalis biofilms. J Periodontal Res 1997: 32: 437-477.
39. Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 2004: 19: 150-154.